Effects of a tailored dose of varenicline on post-quitting urges to smoke

Update Il y a 5 ans
Reference: EUCTR2010-022335-11

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The principle question this project plans to answer is to determine if a tailored dose of varenicline provides better withdrawal and craving relief in the first week of abstinence than a standard varenicline dose. The primary outcome measure will be the rating of urges to smoke one week after the target quit date assessed by Mood and Physical Symptoms Scale [MPSS] (West and Hajek 2004).


Inclusion criteria

  • Tobacco dependence (smoking cessation)

Links